Re-tuning responses in the visual cortex
New research led by Shigeru Tanaka of the University of Electro-Communications and visiting scientist at the RIKEN Brain Science Institute has shown that the responses of cells in the visual cortex can be ...
Neuroscience
Dec 21, 2012 |
not rated yet |
0
Scientists identify new biomarker for cancer in bone marrow: Promise for patients of multiple myeloma
Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not ...
Cancer
Dec 13, 2012 |
not rated yet |
0
Pre-transplant umbilical cord blood expansion speeds establishment of new blood supply in patients
Donated umbilical cord blood establishes a new blood supply in patients more quickly after transplantation when it is first expanded in the lab on a bed of cells that mimics conditions in the bone marrow, researchers report ...
Medical research
Dec 12, 2012 |
not rated yet |
0
|
US doctors defeat leukemia with modified HIV (Update)
US doctors say they have saved a seven-year-old girl who was close to dying from leukemia by pioneering the use of an unlikely ally: a modified form of the HIV virus.
Medical research
Dec 11, 2012 |
5 / 5 (13) |
1
Leukemia patients remain in remission more than two years after engineered T cell therapy
Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the ...
Cancer
Dec 10, 2012 |
5 / 5 (2) |
0
Temple scientists target DNA repair to eradicate leukemia stem cells
Despite treatment with imatinib, a successful drug that targets chronic myeloid leukemia (CML), a deadly type of cancer, some patients may continue to be at risk for relapse because a tiny pool of stem cells is resistant ...
Cancer
Dec 09, 2012 |
5 / 5 (3) |
0
|
Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo
Researchers have demonstrated that combination therapy with PU-H71 and ruxolitinib increases the durability and effectiveness of a treatment that had previously shown limited utility for patients with myelofibrosis.
Cancer
Dec 09, 2012 |
not rated yet |
0
Targeting histone deacetylases as a new strategy for graft versus host disease prevention
New research shows that the addition of the oral anti-cancer agent vorinostat to standard therapy given before, during, and after hematopoietic stem cell transplantation (HSCT) may safely reduce the incidence and severity ...
Medical research
Dec 09, 2012 |
not rated yet |
0
More than a third of high-risk leukemia patients respond to an experimental new drug
A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial. In more than a third of participants, the leukemia was completely ...
Medications
Dec 09, 2012 |
not rated yet |
0
New drug cuts risk of deadly transplant side effect in half
A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive ...
Medical research
Dec 09, 2012 |
not rated yet |
0
Pre-clinical data shows Angiocidin effective against leukemia
Angiocidin, a novel tumor-inhibiting protein, has been shown to reduce acute myeloid leukemia (AML) cells in vivo by almost two-thirds in pre-clinical experiments.
Cancer
Dec 09, 2012 |
not rated yet |
0
Gene therapy as a new option for bone defects
(Medical Xpress)—Gene therapy involving modified stem cells obtained from fatty tissue and bone marrow could represent a new option for the treatment of severe orthopaedic injuries to the extremities. This treatment has ...
Medical research
Dec 07, 2012 |
5 / 5 (1) |
0
|
Research suggests a new strategy to prevent or halt periodontal disease
Periodontitis, a form of chronic gum disease that affects nearly half of the U.S. adult population, results when the bacterial community in the mouth becomes unbalanced, leading to inflammation and eventually bone loss. In ...
Medical research
Dec 07, 2012 |
4.8 / 5 (6) |
0
|
Study finds protein in platelets fight malaria but only for some people
(Medical Xpress)—Researchers in Australia have found that a protein in platelets found naturally in blood has a protective effect against malaria. In their paper published in the journal Science, the team describes how th ...
Medical research
Dec 07, 2012 |
5 / 5 (1) |
0
|
Studying marrow, researchers accelerate blood stem cells
(Medical Xpress)—University of Rochester Medical Center scientists are testing a new approach to speed a patient's recovery of blood counts during a vulnerable period after a stem-cell transplant, according to a study published ...
Medical research
Dec 05, 2012 |
5 / 5 (2) |
0
|
